ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,307.01
      0.00%
      US Tech 100
      18,456.00
      1.25%
      Dow Jones
      39,671.04
      0.00%
      Brent Oil
      82.565
      1.27%
      Bitcoin
      69,413.42
      0.45%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Passage Bio Inc (PASG)

      7. Passage Bio Inc (PASG) News

      PASG

      Passage Bio (PASG)

      Passage Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PASG
      DateTimeSourceHeadlineSymbolCompany
      05/22/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      05/21/20248:00AMGlobeNewswire Inc.Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship AwardNASDAQ:PASGPassage Bio Inc
      05/14/20248:15AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PASGPassage Bio Inc
      05/14/20247:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
      05/14/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      05/14/20247:00AMGlobeNewswire Inc.Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      04/22/20247:00AMGlobeNewswire Inc.Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:PASGPassage Bio Inc
      03/05/20247:00AMGlobeNewswire Inc.Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship ProgramNASDAQ:PASGPassage Bio Inc
      03/04/20245:22PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PASGPassage Bio Inc
      03/04/20244:09PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PASGPassage Bio Inc
      03/04/20247:15AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PASGPassage Bio Inc
      03/04/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      03/04/20247:00AMGlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      02/29/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      02/27/20247:00AMGlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
      02/14/20249:21AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PASGPassage Bio Inc
      02/13/20247:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      02/13/20247:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      01/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      01/03/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      01/03/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      01/03/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
      12/29/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      12/20/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      12/20/20237:00AMGlobeNewswire Inc.Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesNASDAQ:PASGPassage Bio Inc
      11/17/20234:30PMGlobeNewswire Inc.Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PASGPassage Bio Inc
      11/13/20237:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
      11/13/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
      11/13/20237:00AMGlobeNewswire Inc.Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      10/30/20237:00AMGlobeNewswire Inc.Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology ConferenceNASDAQ:PASGPassage Bio Inc
       Showing the most relevant articles for your search:NASDAQ:PASG